OUR TEAM
ANDREA CHOE MD PhD
CEO / CO-FOUNDER
Andrea is the CEO and co-Founder of Holoclara. She received her MD at USC Keck School of Medicine and her PhD at Caltech. Her doctoral work on the evolution of roundworm pheromones laid the foundation for the technology at Holoclara.
HUNG NGUYEN PhD
VP PRECLINICAL
Hung is the VP of Preclinical Development at Holoclara. He brings more than 28 years of drug development expertise from research to clinic, including 18 years at Amgen. He received his PhD from the University of Pennsylvania.
SCIENTIST
Katie is a Scientist at Holoclara with a focus on immunology. She completed her postdoctoral work at Cedars Sinai, studying the role of the microbiome in cancer therapy. She received her PhD at UCLA.
SCIENTIST
Nick is a Scientist at Holoclara with a focus on computational biology. He completed his postdoctoral work at UC Berkeley, using single cell transcriptomics to characterize novel interactions during organogenesis and tissue regeneration. He received his PhD at UC Berkeley.
SR. RESEARCH ASSOCIATE
Winnie is a Senior Research Associate at Holoclara, with a focus on in vivo and in vitro immunology assay development. She brings more than 20 years of experience in the life science industry. She received her BS at UCLA.
BOARD OF DIRECTORS
CHAIRPERSON OF THE BOD
Alan Levy is an experienced serial entrepreneur, having served as the CEO of five life science companies, as senior advisor for Frazier Healthcare, and as senior executive at J&J. He currently serves on the BOD of multiple private and public companies.
FORMER CHIEF COUNSEL FDA
Peter B Hutt is a senior counsel at Covington & Burling LLP, where he specializes in Food and Drug Law. Peter is among the top health care lawyers and FDA regulatory specialists in the US. He received his Bachelor of Laws at Harvard and his Master of Laws at NYU.
NEAL BHADKAMKAR PhD
GENERAL PARTNER, BOLD CAPITAL
Neal Bhadkamkar is a General Partner at Bold Capital. He brings more than 30 years of investment and start-up experience. He has previously served as General Partner of Monitor Ventures and Head of Commercialization for the Paul Allen-backed incubator, Interval Research. He received his PhD from Stanford University and his MBA from Harvard.
CEO ARCADIA SCIENCES,
Seemay Chou is the CEO and co-founder of Arcadia Sciences. Seemay previously held a position as Assistant Professor in Biochemistry and Biophysics at UCSF. Seemay is also co-founder and CEO of Trove Biolabs. She received a PhD in Molecular Cell Biology from UC Berkeley.
PATRICK ZHANG
INVESTOR, HORIZONS VENTURES
Patrick Zhang is an investor at Horizons Ventures, where he leads biotechnology and healthcare investments. He has previously served as a financial advisor at Morgan Stanley. He received his BS in chemical engineering from UCLA and MBA from Columbia Business School.
ADVISORS
PROFESSOR OF BIOLOGY, CALTECH
Paul Sternberg is a co-founder of Holoclara and is a Professors at Caltech. He is an expert in the field of genetics, using computational biology on the model organism, C. elegans, as well as other roundworms, as a model for experimental biology. Paul serves as a primary investigator for online biological database, Wormbase, and for the Gene Ontology Consortium. He has had an academic background at UCSF and MIT.
PROFESSOR OF CHEMISTRY, CORNELL /BTI
Frank Schroeder is a co-founder of Holoclara and Professor of Chemistry at Cornell University. He is a leader in natural products chemistry and developed new strategies for the identification of bioactive small molecules via untargeted comparative metabolomics. He has characterized key biochemical pathways in the model organism, C. elegans, and diverse microbiota. He has had an academic background at the University of Hamburg and Harvard.
PROFESSOR OF BIOLOGY, CALTECH
David Anderson is an HHMI Investigator and Professor of Biology at Caltech, where he serves as the Director of the Chen Institute. David is at the forefront of elucidating the neural circuitry of innate behaviors; his awards include the NSF Presidential Young Investigator Award & Paul Allen Distinguished Investigator Award. He has had an academic background at Harvard, Rockefeller University and Columbia University.
RICK MAIZELS PhD
PROFESSOR OF PARASITOLOGY, GLASGOW
Rick Maizels is an immunologist and Professor of Parasitology at the University of Glasgow. He is a leader in the field of helminthic immunomodulation, elucidating out how parasites modify host immunity. He has had an academic background at National Institute for Medical Research (NIMR), Imperial College of London, University of Edinburgh, UCLA, and Caltech.
PROFESSOR OF CHEMISTRY, CALTECH
Brian Stoltz is an entrepreneur and Professor of Chemistry at Caltech. He is a leading expert In chemical synthesis and has a focus on innovating processes to synthesize unique molecules with novel structural, biological, and physical properties. He is the co-founder of 1200 Pharma and DnaTwo. He has had an academic background at Yale and Harvard.
CHAIRMAN, BINX HEALTH/MIRVIE
Stan Lapidus is an inventor and entrepreneur who currently serves on a number of healthcare and medical technology boards. He has been the founding CEO of three medical diagnostics companies, two of them being among the most successful diagnostic startups in biotech, Cytyc Corp and EXACT Sciences.
CEO/CO-FOUNDER PENDULUM
Colleen Cutcliffe is the CEO and co-founder of Pendulum Therapeutics, with several programs in the clinical phase. Colleen has over 20 years of experience leading teams in biotech, pharma, and academia. She also serves as the Chair of the BOD of the California Life Science Institute and serves on the leadership board of the American Diabetes Association.
FOUNDER/CEO RETRO BIO
Joe is the CEO of Retro Biosciences, which uses high-throughput, high-dimensional approaches to develop therapies for diseases driven by the biology of aging. Joe has had an academic background at Harvard, MIT, and Caltech, over 100 patents and applications. He founded two prior companies and spent several years as a part-time partner at Y Combinator. He continues to invest in and advise numerous biotechs.
